Document and Entity Information	3 Months Ended
Document and Entity Information	Apr. 30, 2015	May 26, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	STREAMLINE HEALTH SOLUTIONS INC.
Entity Central Index Key	0001008586
Document Type	10-Q
Document Period End Date	Apr. 30, 2015
Amendment Flag	false
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--01-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		18,657,974

Condensed Consolidated Balance Sheets (USD $)	Apr. 30, 2015	Jan. 31, 2015
Current assets:
Cash and cash equivalents	$ 5,269,706	$ 6,522,600
Accounts receivable, net of allowance for doubtful accounts of $700,083 and $665,962, respectively	6,255,485	6,935,270
Contract receivables	248,674	191,465
Prepaid hardware and third-party software for future delivery	30,978	55,173
Prepaid client maintenance contracts	1,006,895	935,858
Other prepaid assets	1,093,834	1,437,680
Deferred income taxes	220,004	220,004
Other current assets	114,052	207,673
Total current assets	14,239,628	16,505,723
Property and equipment:
Computer equipment	2,325,641	2,381,923
Computer software	750,532	964,857
Office furniture, fixtures and equipment	683,443	683,443
Leasehold improvements	727,654	724,015
Property and equipment, gross	4,487,270	4,754,238
Accumulated depreciation and amortization	(1,683,426)	(1,617,423)
Property and equipment, net	2,803,844	3,136,815
Contract receivables, less current portion	34,842	43,553
Capitalized software development costs, net of accumulated amortization of $12,628,936 and $11,846,468, respectively	8,414,650	9,197,118
Intangible assets, net of accumulated amortization of $3,663,913 and $3,326,683, respectively	9,163,087	9,500,317
Deferred financing costs, net of accumulated amortization of $31,330 and $13,677, respectively	323,349	387,199
Goodwill	16,184,667	16,184,667
Other	826,603	823,723
Total non-current assets	37,751,042	39,273,392
Total assets	51,990,670	55,779,115
Current liabilities:
Accounts payable	1,718,689	2,298,851
Accrued compensation	511,946	865,865
Accrued other expenses	779,523	563,838
Current portion of long-term debt	562,500	500,000
Deferred revenues	8,587,107	9,289,076
Current portion of capital lease obligations	766,442	781,961
Total current liabilities	12,926,207	14,299,591
Non-current liabilities:
Term loans	9,312,500	9,500,000
Warrants liability	567,916	1,834,380
Royalty liability	2,403,830	2,385,826
Lease incentive liability	352,155	342,129
Capital lease obligations	399,408	582,911
Deferred revenues, less current portion	1,203,125	964,933
Deferred income tax liabilities	220,005	229,579
Total non-current liabilities	14,458,939	15,839,758
Total liabilities	27,385,146	30,139,349
Series A 0% Convertible Redeemable Preferred Stock, $.01 par value per share, $8,849,985 redemption value, 4,000,000 shares authorized, 2,949,995 shares issued and outstanding, net of unamortized preferred stock discount of $1,916,350 and $2,212,007, respectively	6,933,635	6,637,978
Stockholders’ equity:
Common stock, $.01 par value per share, 45,000,000 shares authorized; 18,657,974 and 18,553,389 shares issued and outstanding, respectively	186,580	185,534
Additional paid in capital	78,925,512	78,390,424
Accumulated deficit	(61,440,203)	(59,574,170)
Total stockholders’ equity	17,671,889	19,001,788
Total liability and stockholders' equity	$ 51,990,670	$ 55,779,115

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	3 Months Ended	12 Months Ended
	Apr. 30, 2015	Jan. 31, 2015
Allowance for doubtful accounts	$ 700,083	$ 665,962
Accumulated amortization of capitalized software development costs	12,628,936	11,846,468
Accumulated amortization	3,663,913	3,326,683
Deferred financing costs, accumulated amortization	31,330	13,677
Common stock, par value (dollars per share)	$ 0.01	$ 0.01
Number of authorized shares of common stock	45,000,000	45,000,000
Common stock, shares issued	18,657,974	18,553,389
Common stock, shares outstanding	18,657,974	18,553,389
Series A Preferred Stock
Preferred stock dividend rate	0.00%	0.00%
Convertible redeemable preferred stock, par value (dollars per share)	$ 0.01	$ 0.01
Convertible redeemable preferred stock, redemption value	8,849,985	8,849,985
Convertible redeemable preferred stock, shares authorized	4,000,000	4,000,000
Convertible redeemable preferred stock, shares issued	2,949,995	2,949,995
Convertible redeemable preferred stock, shares outstanding	2,949,995	2,949,995
Unamortized preferred stock discount	$ 1,916,350	$ 2,212,007

Condensed Consolidated Statements of Operations (USD $)	3 Months Ended
Condensed Consolidated Statements of Operations (USD $)	Apr. 30, 2015	Apr. 30, 2014
Revenues:
Systems sales	$ 298,616	$ 339,205
Professional services	350,959	608,951
Maintenance and support	3,654,065	4,171,812
Software as a service	1,865,802	1,831,202
Total revenues	6,169,442	6,951,170
Operating expenses:
Cost of systems sales	726,791	835,468
Cost of professional services	771,496	986,425
Cost of maintenance and support	816,905	960,186
Cost of software as a service	738,831	771,579
Selling, general and administrative	4,506,174	4,640,456
Research and development	2,224,193	2,350,443
Total operating expenses	9,784,390	10,544,557
Operating loss	(3,614,948)	(3,593,387)
Other income (expense):
Interest expense	(243,941)	(169,478)
Miscellaneous income	1,988,974	1,092,771
Loss before income taxes	(1,869,915)	(2,670,094)
Income tax benefit (expense)	3,882	(1,145)
Net loss	(1,866,033)	(2,671,239)
Less: deemed dividends on Series A Preferred Shares	(295,657)	(229,766)
Net loss attributable to common shareholders	$ (2,161,690)	$ (2,901,005)
Basic net loss per common share, dollars per share	$ (0.12)	$ (0.16)
Number of shares used in basic per common share computation	18,600,957	18,146,232
Diluted net loss per common share, dollars per share	$ (0.12)	$ (0.16)
Number of shares used in diluted per common share computation	18,600,957	18,146,232

Consolidated Statements of Comprehensive Loss Statement (USD $)	3 Months Ended
	Apr. 30, 2015	Apr. 30, 2014
Statement of Comprehensive Income [Abstract]
Net loss	$ (1,866,033)	$ (2,671,239)
Other comprehensive loss, net of tax:
Fair value of interest rate swap liability	0	(21,714)
Other comprehensive loss	0	(21,714)
Comprehensive loss	$ (1,866,033)	$ (2,692,953)

Condensed Consolidated Statements of Cash Flows (USD $)	3 Months Ended
Condensed Consolidated Statements of Cash Flows (USD $)	Apr. 30, 2015	Apr. 30, 2014
Operating activities:
Net loss	$ (1,866,033)	$ (2,671,239)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	314,325	150,660
Amortization of capitalized software development costs	782,468	916,868
Amortization of intangible assets	337,230	358,879
Amortization of other deferred costs	59,362	38,838
Valuation adjustment for warrants liability	(1,266,464)	(1,138,021)
Share-based compensation expense	651,982	442,876
Other valuation adjustments	43,412	38,200
Loss on disposal of property and equipment	34,228	0
Provision for accounts receivable	80,086	0
Deferred tax benefit	(9,574)	0
Changes in assets and liabilities, net of effects of acquisitions:
Accounts and contract receivables	551,201	528,680
Other assets	346,036	(927,325)
Accounts payable	(536,076)	(142,824)
Accrued expenses	(117,157)	(378,084)
Deferred revenues	(463,777)	(1,161,803)
Net cash used in operating activities	(1,058,751)	(3,944,295)
Investing activities:
Purchases of property and equipment	(15,582)	(592,498)
Capitalization of software development costs	0	(193,379)
Payment for acquisition, net of cash received	0	(5,890,402)
Net cash used in investing activities	(15,582)	(6,676,279)
Financing activities:
Principal repayments on term loan	(125,000)	(202,380)
Principal payments on capital lease obligation	(199,022)	(23,985)
Recovery (payment) of deferred financing costs	2,111	(112,800)
Proceeds from exercise of stock options and stock purchase plan	143,350	592
Net cash used in financing activities	(178,561)	(338,573)
Decrease in cash and cash equivalents	(1,252,894)	(10,959,147)
Cash and cash equivalents at beginning of period	6,522,600	17,924,886
Cash and cash equivalents at end of period	$ 5,269,706	$ 6,965,739

Basis of Presentation	3 Months Ended
Basis of Presentation	Apr. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION	BASIS OF PRESENTATION The accompanying unaudited Condensed Consolidated Financial Statements have been prepared by Streamline Health Solutions, Inc. (“we”, “us”, “our”, or the “Company”), pursuant to the rules and regulations applicable to quarterly reports on Form 10-Q of the U.S. Securities and Exchange Commission. Certain information and note disclosures normally included in annual financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted pursuant to those rules and regulations, although we believe that the disclosures made are adequate to make the information not misleading. In the opinion of our management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the Condensed Consolidated Financial Statements have been included. These Condensed Consolidated Financial Statements should be read in conjunction with the consolidated financial statements and notes thereto included in our most recent annual report on Form 10-K, Commission File Number 0-28132. Operating results for the three months ended April 30, 2015 are not necessarily indicative of the results that may be expected for the fiscal year ending January 31, 2016.

Summary of Significant Accounting Policies

3 Months Ended

Apr. 30, 2015

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Our significant accounting policies are presented in “Note 2 – Significant Accounting Policies” in the fiscal year 2014 Annual Report on Form 10-K. Users of financial information for interim periods are encouraged to refer to the footnotes to the consolidated financial statements contained in the Annual Report on Form 10-K when reviewing interim financial results.

Use of Estimates

The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

Fair Value of Financial Instruments

The Financial Accounting Standards Board’s (“FASB”) authoritative guidance on fair value measurements establishes a framework for measuring fair value, and expands disclosure about fair value measurements. This guidance enables the reader of the financial statements to assess the inputs used to develop those measurements by establishing a hierarchy for ranking the quality and reliability of the information used to determine fair values. Under this guidance, assets and liabilities carried at fair value must be classified and disclosed in one of the following three categories:

Level 1: Quoted market prices in active markets for identical assets or liabilities.

Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data.

Level 3: Unobservable inputs that are not corroborated by market data.

The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses approximate fair value based on the short-term maturity of these instruments. Cash and cash equivalents are classified as Level 1. The carrying amount of our long-term debt approximates fair value since the interest rates being paid on the amounts approximate the market interest rate. Long-term debt is and, prior to its termination, the interest rate swap was classified as Level 2. The initial fair value of royalty liability and warrants liability was determined by management with the assistance of an independent third-party valuation specialist, and by management thereafter. The fair value of warrants liability as of January 31, 2015 was also determined by management with the assistance of an independent third-party valuation specialist using a binomial model. We used the Black-Scholes option pricing model to estimate the fair value of warrants liability as of April 30, 2015. The fair value of the royalty liability is determined based on the probability-weighted revenue scenarios for the Looking Glass® Clinical Analytics solution licensed from Montefiore Medical Center (discussed below). The contingent consideration for royalty liability and warrants liability are classified as Level 3.

Revenue Recognition

We derive revenue from the sale of internally-developed software either by licensing or by software as a service (“SaaS”), through the direct sales force or through third-party resellers. Licensed, locally-installed clients utilize our support and maintenance services for a separate fee, whereas SaaS fees include support and maintenance. We also derive revenue from professional services that support the implementation, configuration, training, and optimization of the applications. Additional revenues are also derived from reselling third-party software and hardware components.

We recognize revenue in accordance with Accounting Standards Codification (ASC) 985-605, Software-Revenue Recognition, and ASC 605-25, Revenue Recognition — Multiple-element arrangements. We commence revenue recognition when all of the following criteria have been met:


•	Persuasive evidence of an arrangement exists,


•	Delivery has occurred or services have been rendered,


•	The arrangement fees are fixed or determinable, and


•	Collectibility is reasonably assured.

If we determine that any of the above criteria have not been met, we will defer recognition of the revenue until all the criteria have been met. Maintenance and support and SaaS agreements are generally non-cancelable or contain significant penalties for early cancellation, although clients typically have the right to terminate their contracts for cause if we fail to perform material obligations. However, if non-standard acceptance periods, non-standard performance criteria, or cancellation or right of refund terms are required, revenue is recognized upon the satisfaction of such criteria, as applicable.

Revenues from resellers are recognized gross of royalty payments to resellers.

Multiple Element Arrangements

We follow the accounting revenue guidance under Accounting Standards Update (ASU) 2009-13, Multiple-Deliverable Revenue Arrangements — a consensus of the FASB Emerging Issues Task Force.

Terms used in evaluation are as follows:


•	VSOE — the price at which an element is sold as a separate stand-alone transaction


•	TPE — the price of an element, charged by another company that is largely interchangeable in any particular transaction


•	ESP — our best estimate of the selling price of an element of the transaction

We follow accounting guidance for revenue recognition of multiple-element arrangements to determine whether such arrangements contain more than one unit of accounting. Multiple-element arrangements require the delivery or performance of multiple solutions, services and/or rights to use assets. To qualify as a separate unit of accounting, the delivered item must have value to the client on a stand-alone basis. Stand-alone value to a client is defined in the guidance as those that can be sold separately by any vendor or the client could resell the item on a stand-alone basis. Additionally, if the arrangement includes a general right of return relative to the delivered item, delivery or performance of the undelivered item or items must be considered probable and substantially in the control of the vendor.

We have a defined pricing methodology for all elements of the arrangement and proper review of pricing to ensure adherence to our policies. Pricing decisions include cross-functional teams of senior management, which uses market conditions, expected contribution margin, size of the client’s organization, and pricing history for similar solutions when establishing the selling price.

Software as a Service

We use ESP to determine the value for a software-as-a-service arrangement as we cannot establish VSOE and TPE is not a practical alternative due to differences in functionality from our competitors. Similar to proprietary license sales, pricing decisions rely on the relative size of the client purchasing the solution and include calculating the equivalent value of maintenance and support on a present value basis over the term of the initial agreement period. Typically revenue recognition commences upon client go live on the system and is recognized ratably over the contract term.

System Sales

We use the residual method to determine fair value for proprietary software licenses sold in a multi-element arrangement. Under the residual method, we allocate the total value of the arrangement first to the undelivered elements based on their VSOE and allocate the remainder to the proprietary software license fees.

Typically pricing decisions for proprietary software rely on the relative size and complexity of the client purchasing the solution. Third-party components are resold at prices based on a cost-plus margin analysis. The proprietary software and third-party components do not need any significant modification to achieve their intended use. When these revenues meet all criteria for revenue recognition and are determined to be separate units of accounting, revenue is recognized. Typically this is upon shipment of components or electronic download of software. Proprietary licenses are perpetual in nature, and license fees do not include rights to version upgrades, fixes or service packs.

Maintenance and Support Services

The maintenance and support components are not essential to the functionality of the software, and clients renew maintenance contracts separately from software purchases at renewal rates materially similar to the initial rate charged for maintenance on the initial purchase of software. We use VSOE of fair value to determine fair value of maintenance and support services. Rates are set based on market rates for these types of services, and our rates are comparable to rates charged by our competitors, which are based on the knowledge of the marketplace by senior management. Generally, maintenance and support is calculated as a percentage of the list price of the proprietary license being purchased by a client. Clients have the option of purchasing additional annual maintenance service renewals each year for which rates are not materially different from the initial rate but typically include a nominal rate increase based on the consumer price index. Annual maintenance and support agreements entitle clients to technology support, upgrades, bug fixes and service packs.

Term Licenses

We cannot establish VSOE fair value of the undelivered element in term license arrangements. However, as the only undelivered element is post-contract customer support, the entire fee is recognized ratably over the contract term. Typically revenue recognition commences once the client goes live on the system. Similar to proprietary license sales, pricing decisions rely on the relative size of the client purchasing the solution. The software portion of our Looking Glass® Coding & CDI products generally do not require material modification to achieve their contracted function.

Professional Services

Professional services components that are not essential to the functionality of the software, from time to time, are sold separately by us. Similar services are sold by other vendors, and clients can elect to perform similar services in-house. When professional services revenues are a separate unit of accounting, revenues are recognized as the services are performed.

Professional services components that are essential to the functionality of the software and are not considered a separate unit of accounting are recognized in revenue ratably over the life of the client, which approximates the duration of the initial contract term. We defer the associated direct costs for salaries and benefits expense for professional services contracts. These deferred costs will be amortized over the identical term as the associated revenues. As of April 30, 2015 and January 31, 2015, we had deferred costs of $573,000 and $570,000, respectively, net of accumulated amortization of $171,000 and $275,000, respectively. Amortization expense of these costs was $42,000 and $27,000 for the three months ended April 30, 2015 and 2014, respectively.

We use VSOE of fair value based on the hourly rate charged when services are sold separately, to determine fair value of professional services. We typically sell professional services on an hourly-fee basis. We monitor projects to assure that the expected and historical rate earned remains within a reasonable range to the established selling price.

Severances

From time to time, we enter into termination agreements with associates that may include supplemental cash payments, as well as contributions to health and other benefits for a specific time period subsequent to termination. For the three months ended April 30, 2015 and 2014, we incurred $6,000 and $451,000 in severance expenses, respectively. At April 30, 2015 and January 31, 2015, we had accrued severances of $31,000 and $159,000, respectively.

Equity Awards

We account for share-based payments based on the grant-date fair value of the awards with compensation cost recognized as expense over the requisite vesting period. We incurred total compensation expense related to stock-based awards of $652,000 and $443,000 for the three months ended April 30, 2015 and 2014, respectively.

The fair value of the stock options granted is estimated at the date of grant using a Black-Scholes option pricing model. The option pricing model inputs (such as, expected term, expected volatility, and risk-free interest rate) impact the fair value estimate. Further, the forfeiture rate impacts the amount of aggregate compensation. These assumptions are subjective and are generally derived from external (such as, risk-free rate of interest) and historical (such as, volatility factor, expected term, and forfeiture rates) data. Future grants of equity awards accounted for as stock-based compensation could have a material impact on reported expenses depending upon the number, value, and vesting period of future awards.

We issue restricted stock awards in the form of our common stock. The fair value of these awards is based on the market close price per share on the day of grant. We expense the compensation cost of these awards as the restriction period lapses, which is typically a one-year service period to the Company.

Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis and for tax credit and loss carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. In assessing net deferred tax assets, we consider whether it is more likely than not that some or all of the deferred tax assets will not be realized. We establish a valuation allowance when it is more likely than not that all or a portion of deferred tax assets will not be realized.

We provide for uncertain tax positions and the related interest and penalties based upon management’s assessment of whether certain tax positions are more likely than not to be sustained upon examination by tax authorities. We believe we have appropriately accounted for any uncertain tax positions.

Net Loss Per Common Share

We present basic and diluted earnings per share (“EPS”) data for our common stock. Basic EPS is calculated by dividing the net loss attributable to common stockholders of the Company by the weighted average number of shares of common stock outstanding during the period. Diluted EPS is determined by adjusting the profit or loss attributable to common stockholders and the weighted average number of shares of common stock outstanding adjusted for the effects of all dilutive potential common shares comprised of options granted, unvested restricted stock, warrants and convertible preferred stock. Potential common stock equivalents that have been issued by us related to outstanding stock options, unvested restricted stock and warrants are determined using the treasury stock method, while potential common stock issuable upon conversion of Series A Convertible Preferred Stock are determined using the “if converted” method.

Our unvested restricted stock awards and Series A Convertible Preferred Stock are considered participating securities under ASC 260, Earnings Per Share, which means the security may participate in undistributed earnings with common stock. Our unvested restricted stock awards are considered participating securities because they entitle holders to non-forfeitable rights to dividends or dividend equivalents during the vesting term. The holders of the Series A Convertible Preferred Stock would be entitled to share in dividends, on an as-converted basis, if the holders of common stock were to receive dividends, other than dividends in the form of common stock. In accordance with ASC 260, a company is required to use the two-class method when computing EPS when a company has a security that qualifies as a “participating security.” The two-class method is an earnings allocation formula that determines EPS for each class of common stock and participating security according to dividends declared (or accumulated) and participation rights in undistributed earnings. In determining the amount of net earnings to allocate to common stockholders, earnings are allocated to both common and participating securities based on their respective weighted-average shares outstanding for the period. Diluted EPS for our common stock is computed using the more dilutive of the two-class method or the if-converted method.

In accordance with ASC 260, securities are deemed to not be participating in losses if there is no obligation to fund such losses. For the three months ended April 30, 2015 and 2014, the unvested restricted stock awards and the Series A Convertible Preferred Stock were not deemed to be participating since there was a net loss from operations. As of April 30, 2015, there were 2,949,995 shares of preferred stock outstanding, each share is convertible into one share of our common stock. For the three months ended April 30, 2015 and 2014, the Series A Convertible Preferred Stock would have an anti-dilutive effect if included in diluted EPS and therefore, was not included in the calculation. As of April 30, 2015 and 2014, there were 59,307 and 29,698, respectively, unvested restricted shares of common stock outstanding that were excluded from the calculation as their effect would have been anti-dilutive.

The following is the calculation of the basic and diluted net loss per share of common stock:



	Three Months Ended
	April 30, 2015			April 30, 2014
Net loss	$	(1,866,033	)	$	(2,671,239	)
Less: deemed dividends on Series A Preferred Stock	(295,657		)	(229,766		)
Net loss attributable to common shareholders	$	(2,161,690	)	$	(2,901,005	)
Weighted average shares outstanding used in basic per common share computations	18,600,957			18,146,232
Stock options and restricted stock	—			—
Number of shares used in diluted per common share computation	18,600,957			18,146,232
Basic net loss per share of common stock	$	(0.12	)	$	(0.16	)
Diluted net loss per share of common stock	$	(0.12	)	$	(0.16	)

Diluted net loss per share excludes the effect of 2,641,536 and 2,605,552 outstanding stock options for the three months ended April 30, 2015 and 2014, respectively. The inclusion of these shares would be anti-dilutive. For the three months ended April 30, 2015 and 2014, the warrants to purchase 1,400,000 shares of common stock would have an anti-dilutive effect if included in diluted net loss per share and therefore were not included in the calculation.

Recent Accounting Pronouncements

In August 2014, the FASB issued an accounting standard update relating to disclosures of uncertainties about an entity’s ability to continue as a going concern. The update provides guidance about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures in the event that there is such substantial doubt. The update will be effective for us on February 1, 2017.

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in ASC 605, Revenue Recognition. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. This guidance is effective for us on February 1, 2017. Early adoption is not permitted. The guidance is to be applied using one of two retrospective application methods. We are currently evaluating the impact of the adoption of this accounting standard update on our internal processes, operating results, and financial reporting.

In April 2015, the FASB issued an accounting standard update relating to simplifying the presentation of debt issuance costs. The amendments in this update require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The update

will be effective for us on February 1, 2016.

Acquisitions and Strategic Agreements

3 Months Ended

Apr. 30, 2015

Business Combinations [Abstract]

ACQUISITIONS AND STRATEGIC AGREEMENTS

On October 25, 2013, we entered into a Software License and Royalty Agreement (the “Royalty Agreement”) with Montefiore Medical Center (“Montefiore”) pursuant to which Montefiore granted us an exclusive, worldwide 15-year license of Montefiore’s proprietary clinical analytics platform solution, Clinical Looking Glass® (“CLG”), now known as our Looking Glass® Clinical Analytics solution. In addition, Montefiore assigned to us the existing license agreement with a customer using CLG. As consideration under the Royalty Agreement, Streamline paid Montefiore a one-time initial base royalty fee of $3,000,000, and we are obligated to pay on-going quarterly royalty amounts related to future sublicensing of CLG by Streamline. Additionally, Streamline has committed that Montefiore will receive at least an additional $3,000,000 of on-going royalty payments within the first six and one-half years of the license term. As of April 30, 2015 and January 31, 2015, the present value of this royalty liability was $2,404,000 and $2,386,000, respectively

On February 3, 2014, we completed the acquisition of Unibased Systems Architecture, Inc. (“Unibased”), a provider of patient access solutions, including enterprise scheduling and surgery management software, for healthcare organizations throughout the United States, pursuant to an Agreement and Plan of Merger dated January 16, 2014 (the “Merger Agreement”) for a total purchase price of $6,500,000, subject to net working capital and other customary adjustments. A portion of the total purchase price was withheld in escrow as described in the Merger Agreement for indemnification of claimed damages. In April 2015, the Company received $750,000 from the cash withheld in escrow, which is included in miscellaneous income.

Pursuant to the Merger Agreement, we acquired all of the issued and outstanding common stock of Unibased, and Unibased became a wholly-owned subsidiary of Streamline. Under the terms of the Merger Agreement, Unibased stockholders received cash for each share of Unibased common stock held. The purchase price was allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date as follows:



	Balance at February 3, 2014
Assets purchased:
Cash	$	59,000
Accounts receivable	221,000
Other assets	61,000
Internally-developed software	2,017,000
Client relationships	647,000
Trade name	26,000
Goodwill (1)	4,251,000
Total assets purchased	7,282,000
Liabilities assumed:
Accounts payable and accrued liabilities	362,000
Deferred revenue obligation, net	793,000
Deferred income taxes	9,000
Net assets acquired	$	6,118,000
Cash paid	$	6,118,000

_______________


(1)	Goodwill represents the excess of purchase price over the estimated fair value of net tangible and intangible assets acquired, which is not deductible for tax purposes.

The operating results of Unibased are not material for proforma disclosure.

Leases

3 Months Ended

Apr. 30, 2015

Leases [Abstract]

LEASES

We rent office space and equipment under non-cancelable operating leases that expire at various times through fiscal year 2022. Future minimum lease payments under non-cancelable operating leases for the next five fiscal years are as follows:



	Facilities		Equipment		Fiscal Year Totals
2015 (nine months remaining)	$	755,000	$	2,000	$	757,000
2016	969,000		2,000		971,000
2017	1,007,000		—		1,007,000
2018	1,039,000		—		1,039,000
2019	967,000		—		967,000
Thereafter	1,468,000		—		1,468,000
Total	$	6,205,000	$	4,000	$	6,209,000

Rent and leasing expense for facilities and equipment was $307,000 and $378,000 for the three months ended April 30, 2015 and 2014, respectively.

The Company has a capital lease to finance office equipment purchases. The balance of fixed assets acquired under these capital leases was $1,515,000 as of April 30, 2015 and January 31, 2015, and the balance of accumulated depreciation was $659,000 and $494,000 as of April 30, 2015 and January 31, 2015, respectively. The amortization expense of leased equipment is included in depreciation expense.

Debt

3 Months Ended

Apr. 30, 2015

Debt Disclosure [Abstract]

DEBT

Term Loan and Line of Credit

In December 2013, we amended and restated our previously outstanding senior credit agreement and amended the subordinated credit agreement with Fifth Third Bank to increase the senior term loan to $8,500,000, reduce the interest rates, and extend the maturity of the senior term loan and the revolving line of credit to December 1, 2018 and December 1, 2015, respectively. In January 2014, we paid the subordinated term loan in full. The outstanding senior term loan was secured by substantially all of our assets. The senior term loan principal balance was payable in monthly installments of $101,000, which started in January 2014 and would have continued through the maturity date, with the full remaining unpaid principal balance due at maturity. Borrowings under the senior term loan bore interest at a rate of LIBOR plus 5.25%. However, as a result of our interest rate swap, the interest rate was fixed at 6.42% until October 27, 2014, when the interest rate swap agreement was terminated. Accrued and unpaid interest on the senior term loan was due monthly through maturity. We paid $116,000 in closing fees in connection with this senior term loan, which was recorded as a debt discount and was being amortized to interest expense over the term of the loan using the effective interest method.

Borrowings under the revolving line of credit bore interest at a rate equal to LIBOR plus 3.50%. A commitment fee of 0.40% was incurred on the unused revolving line of credit balance, and was payable quarterly.

On November 21, 2014, we entered into a Credit Agreement (the “Credit Agreement”) with Wells Fargo Bank, N.A., as administrative agent, and other lender parties thereto. Pursuant to the Credit Agreement, the lenders agreed to provide a $10,000,000 senior term loan and a $5,000,000 revolving line of credit to our primary operating subsidiary. Amounts outstanding under the Credit Agreement bear interest at either LIBOR or the base rate, as elected by the Company, plus an applicable margin. Subject to the Company’s leverage ratio, the applicable LIBOR rate margin varied from 4.25% to 5.25%, and the applicable base rate margin varied from 3.25% to 4.25%. Pursuant to the terms of the amendment to the Credit Agreement entered into as of April 15, 2015, the applicable LIBOR rate margin was changed to vary from 4.25% to 6.25%, and the applicable base rate margin was changed to vary from 3.25% to 5.25%. The term loan and line of credit mature on November 21, 2019 and provide support for working capital, capital expenditures and other general corporate purposes, including permitted acquisitions. At closing, the Company repaid indebtedness under its prior credit facility using approximately $7,400,000 of the proceeds provided by the term loan. The prior credit facility with Fifth Third Bank was terminated concurrent with the entry of the Credit Agreement and unamortized debt financing costs and discount of $315,000 associated with the terminated debt was included in loss on early extinguishment of debt. Financing costs of $355,000 associated with the new credit facility are being amortized over its term on a straight-line basis, which is not materially different from the effective interest method.

The Credit Agreement includes customary financial covenants, including the requirements that the Company maintain minimum liquidity and achieve certain minimum EBITDA levels. In addition, the credit facility prohibits the Company from paying dividends on the common and preferred stock. In April 2015 the Credit Agreement was amended to increase the applicable LIBOR rate margin, which will vary from 4.25% to 6.25%, and to reset the financial covenants. As such, the Company is required to maintain minimum liquidity of at least (i) $5,000,000 through April 15, 2015, (ii) $6,500,000 from April 16, 2015 through and including July 30, 2015, (iii) $7,000,000 from July 31, 2015 through and including January 30, 2016, and (iv) $7,500,000 from January 31, 2016 through and including the maturity date of the credit facility.

The following table shows our future minimum EBITDA covenant thresholds, as modified by the amendment to the Credit Agreement:



For the four-quarter period ending	Minimum EBITDA
April 30, 2015	$	(2,500,000	)
July 31, 2015	(1,750,000		)
October 31, 2015	(750,000		)
January 31, 2016	500,000

For the four-quarter period ending April 30, 2016, and fiscal quarters thereafter, the minimum EBITDA will be determined within 30 days following delivery of, and based upon, the projections then most recently delivered by the Company.

As of April 30, 2015, the Company had no outstanding borrowings under the revolving line of credit, and had accrued $3,000 in unused line fees.

Outstanding principal balances on debt consisted of the following at:



	April 30, 2015		January 31, 2015
Senior term loan	$	9,875,000	$	10,000,000
Capital lease	1,166,000		1,365,000
Total	11,041,000		11,365,000
Less: Current portion	1,329,000		1,282,000
Non-current portion of debt	$	9,712,000	$	10,083,000

Future principal repayments of debt consisted of the following at April 30, 2015:



	Senior Term Loan		Capital Lease (1)		Total
2015	$	375,000	$	641,000	$	1,016,000
2016	750,000		511,000		1,261,000
2017	1,000,000		93,000		1,093,000
2018	1,000,000		—		1,000,000
2019	6,750,000		—		6,750,000
Total repayments	$	9,875,000	$	1,245,000	$	11,120,000

_______________


(1)	Future minimum lease payments include principal plus interest.

Note Payable

In November 2013, as part of the settlement of the earn-out consideration in connection with the Interpoint acquisition, we issued an unsecured, subordinated three-year note in the amount of $900,000 that was originally scheduled to mature on November 1, 2016 and accrued interest on the unpaid principal amount actually outstanding at a per annum rate equal to 8%. The promissory note had annual principal payments of $300,000 due on November 1, 2014, 2015 and 2016. At closing of the Credit Agreement with Wells Fargo described above, we repaid our indebtedness under this note using approximately $600,000 of the proceeds provided by the term loan.

Convertible Preferred Stock	3 Months Ended
Convertible Preferred Stock	Apr. 30, 2015
Equity [Abstract]
CONVERTIBLE PREFERRED STOCK	CONVERTIBLE PREFERRED STOCK Series A Convertible Preferred Stock At April 30, 2015, we had 2,949,995 shares of Series A Convertible Redeemable Preferred Stock (the “Preferred Stock”) outstanding. Each share of the Preferred Stock is convertible into one share of the Company's common stock. The Preferred Stock does not pay a dividend; however, the holders are entitled to receive dividends equal (on an as-if-converted-to-common-stock basis) to and in the same form as dividends (other than dividends in the form of common stock) actually paid on shares of the common stock. The Preferred Stock has voting rights on a modified as-if-converted-to-common-stock-basis. The Preferred Stock has a non-participating liquidation right equal to the original issue price plus accrued unpaid dividends, which are senior to the Company’s common stock. The Preferred Stock can be converted to common shares at any time by the holders, or at the option of the Company if the arithmetic average of the daily volume weighted average price of the common stock for the ten day period prior to the measurement date is greater than $8.00 per share, and the average daily trading volume for the 60 day period immediately prior to the measurement date exceeds 100,000 shares. The conversion price is $3.00 per share, subject to certain adjustments. At any time following August 31, 2016, each share of Preferred Stock is redeemable at the option of the holder for an amount equal to the initial issuance price of $3.00 (adjusted to reflect stock splits, stock dividends or similar events) plus any accrued and unpaid dividends thereon. The Preferred Stock are classified as temporary equity as the securities are redeemable solely at the option of the holder.

Summary of Significant Accounting Policies (Policies)

3 Months Ended

Apr. 30, 2015

Accounting Policies [Abstract]

Use of Estimates

Fair Value of Financial Instruments

Level 1: Quoted market prices in active markets for identical assets or liabilities.

Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data.

Level 3: Unobservable inputs that are not corroborated by market data.

Revenue Recognition


•	Persuasive evidence of an arrangement exists,


•	Delivery has occurred or services have been rendered,


•	The arrangement fees are fixed or determinable, and


•	Collectibility is reasonably assured.

Revenues from resellers are recognized gross of royalty payments to resellers.

Multiple Element Arrangements

We follow the accounting revenue guidance under Accounting Standards Update (ASU) 2009-13, Multiple-Deliverable Revenue Arrangements — a consensus of the FASB Emerging Issues Task Force.

Terms used in evaluation are as follows:


•	VSOE — the price at which an element is sold as a separate stand-alone transaction


•	TPE — the price of an element, charged by another company that is largely interchangeable in any particular transaction


•	ESP — our best estimate of the selling price of an element of the transaction

Software as a Service

System Sales

Maintenance and Support Services

Term Licenses

Professional Services

Severances

Equity Awards

Income Taxes

Net Loss Per Common Share

In accordance with ASC 260, securities are deemed to not be participating in losses if there is no obligation to fund such losses.

Recent Accounting Pronouncements

will be effective for us on February 1, 2016.

Summary of Significant Accounting Policies (Tables)

3 Months Ended

Apr. 30, 2015

Accounting Policies [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

The following is the calculation of the basic and diluted net loss per share of common stock:



	Three Months Ended
	April 30, 2015			April 30, 2014
Net loss	$	(1,866,033	)	$	(2,671,239	)
Less: deemed dividends on Series A Preferred Stock	(295,657		)	(229,766		)
Net loss attributable to common shareholders	$	(2,161,690	)	$	(2,901,005	)
Weighted average shares outstanding used in basic per common share computations	18,600,957			18,146,232
Stock options and restricted stock	—			—
Number of shares used in diluted per common share computation	18,600,957			18,146,232
Basic net loss per share of common stock	$	(0.12	)	$	(0.16	)
Diluted net loss per share of common stock	$	(0.12	)	$	(0.16	)

Acquisitions and Strategic Agreements(Tables) (Unibased Systems Architecture, Inc)

3 Months Ended

Apr. 30, 2015

Unibased Systems Architecture, Inc

Business Acquisition [Line Items]

Purchase price allocation of assets and liabilities

The purchase price was allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date as follows:



	Balance at February 3, 2014
Assets purchased:
Cash	$	59,000
Accounts receivable	221,000
Other assets	61,000
Internally-developed software	2,017,000
Client relationships	647,000
Trade name	26,000
Goodwill (1)	4,251,000
Total assets purchased	7,282,000
Liabilities assumed:
Accounts payable and accrued liabilities	362,000
Deferred revenue obligation, net	793,000
Deferred income taxes	9,000
Net assets acquired	$	6,118,000
Cash paid	$	6,118,000

_______________


(1)	Goodwill represents the excess of purchase price over the estimated fair value of net tangible and intangible assets acquired, which is not deductible for tax purposes.

Debt (Tables)

3 Months Ended

Apr. 30, 2015

Debt Disclosure [Abstract]

Schedule of Minimum EBITDA Levels

The following table shows our future minimum EBITDA covenant thresholds, as modified by the amendment to the Credit Agreement:



For the four-quarter period ending	Minimum EBITDA
April 30, 2015	$	(2,500,000	)
July 31, 2015	(1,750,000		)
October 31, 2015	(750,000		)
January 31, 2016	500,000

Summary of term loan and line of credit

Outstanding principal balances on debt consisted of the following at:



	April 30, 2015		January 31, 2015
Senior term loan	$	9,875,000	$	10,000,000
Capital lease	1,166,000		1,365,000
Total	11,041,000		11,365,000
Less: Current portion	1,329,000		1,282,000
Non-current portion of debt	$	9,712,000	$	10,083,000

Schedule of Future Minimum Lease Payments for Capital Leases

Future principal repayments of debt consisted of the following at April 30, 2015:



	Senior Term Loan		Capital Lease (1)		Total
2015	$	375,000	$	641,000	$	1,016,000
2016	750,000		511,000		1,261,000
2017	1,000,000		93,000		1,093,000
2018	1,000,000		—		1,000,000
2019	6,750,000		—		6,750,000
Total repayments	$	9,875,000	$	1,245,000	$	11,120,000

_______________


(1)	Future minimum lease payments include principal plus interest.

Summary of Significant Accounting Policies - (Details) (USD $)	3 Months Ended		12 Months Ended
	Apr. 30, 2015	Apr. 30, 2014	Jan. 31, 2015
Class of Stock [Line Items]
Deferred professional costs	$ 573,000		$ 570,000
Accumulated amortization	171,000		275,000
Amortization expense	42,000	27,000
Severance expenses	6,000	451,000
Accrued severances	31,000		159,000
Share-based compensation expense	$ 651,982	$ 442,876
Series A Preferred Stock
Class of Stock [Line Items]
Convertible redeemable preferred stock, shares outstanding	2,949,995		2,949,995
Restricted Stock
Class of Stock [Line Items]
Antidilutive securities	59,307	29,698

Summary of Significant Accounting Policies - Earnings Per Share (Details) (USD $)	3 Months Ended
	Apr. 30, 2015	Apr. 30, 2014
Schedule of Earnings Per Share Basic and Diluted by Common Class [Line Items]
Net loss	$ (1,866,033)	$ (2,671,239)
Less: deemed dividends on Series A Preferred Shares	(295,657)	(229,766)
Net loss attributable to common shareholders	$ (2,161,690)	$ (2,901,005)
Weighted average shares outstanding used in basic per common share computations	18,600,957	18,146,232
Stock options and restricted stock	0	0
Number of shares used in diluted per common share computation	18,600,957	18,146,232
Basic net loss per common share, dollars per share	$ (0.12)	$ (0.16)
Diluted net loss per common share, dollars per share	$ (0.12)	$ (0.16)
Employee Stock Option
Schedule of Earnings Per Share Basic and Diluted by Common Class [Line Items]
Antidilutive securities	2,641,536	2,605,552
Warrant
Schedule of Earnings Per Share Basic and Diluted by Common Class [Line Items]
Antidilutive securities	1,400,000	1,400,000

Acquisitions and Strategic Agreements - Montefiore (Details) (Montefiore Medical Center, USD $) In Thousands, unless otherwise specified	0 Months Ended	3 Months Ended	12 Months Ended
	Oct. 25, 2013	Apr. 30, 2015	Jan. 31, 2015
Montefiore Medical Center
Business Acquisition [Line Items]
Proprietary lease term	15 years
Cash paid	$ 3,000
Periodic royalty payment, term	6 years 6 months
Royalty liability		$ 2,404	$ 2,386

Acquisitions and Strategic Agreements - Unibased (Details) (USD $)			0 Months Ended		3 Months Ended
	Apr. 30, 2015	Jan. 31, 2015	Feb. 03, 2014 Unibased Systems Architecture, Inc	Feb. 03, 2014 Unibased Systems Architecture, Inc	Apr. 30, 2015 Unibased Systems Architecture, Inc	Feb. 03, 2014 Internally-developed software Unibased Systems Architecture, Inc	Feb. 03, 2014 Client relationships Unibased Systems Architecture, Inc	Feb. 03, 2014 Trade name Unibased Systems Architecture, Inc
Business Acquisition [Line Items]
Total consideration transferred			$ 6,500,000
Amount received held in escrow					750,000
Assets purchased:
Cash				59,000
Accounts receivable				221,000
Other assets				61,000
Intangible assets						2,017,000	647,000	26,000
Goodwill	16,184,667	16,184,667		4,251,000
Total assets purchased				7,282,000
Liabilities assumed:
Accounts payable and accrued liabilities				362,000
Deferred revenue obligation, net				793,000
Deferred income taxes				9,000
Net assets acquired				6,118,000
Cash paid				$ 6,118,000

Leases - (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Apr. 30, 2015	Apr. 30, 2014	Jan. 31, 2015
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]
2015 (nine months remaining)	$ 757
2016	971
2017	1,007
2018	1,039
2019	967
Thereafter	1,468
Total	6,209
Rent expense	307	378
Fixed assets	1,515		1,515
Accumulated depreciation	659		494
Facilities
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]
2015 (nine months remaining)	755
2016	969
2017	1,007
2018	1,039
2019	967
Thereafter	1,468
Total	6,205
Equipment
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]
2015 (nine months remaining)	2
2016	2
2017	0
2018	0
2019	0
Thereafter	0
Total	$ 4

Debt - Term Loan and Line of Credit Narrative (Details) (USD $)	1 Months Ended				3 Months Ended		0 Months Ended	3 Months Ended				1 Months Ended	3 Months Ended	0 Months Ended
	Jan. 31, 2014 Senior Notes	Apr. 30, 2015 Senior Notes	Jan. 01, 2014 Senior Notes	Dec. 31, 2013 Senior Notes	Apr. 30, 2015 Revolving Credit Facility	Apr. 30, 2014 Revolving Credit Facility	Nov. 21, 2014 Credit Agreement	Apr. 30, 2014 Credit Agreement	Apr. 30, 2015 Credit Agreement	Nov. 21, 2014 Credit Agreement Revolving Credit Facility	Nov. 21, 2014 Credit Agreement Senior term loan	Dec. 31, 2013 LIBOR Senior Notes	Apr. 30, 2015 LIBOR Revolving Credit Facility	Apr. 15, 2015 Minimum LIBOR Credit Agreement	Nov. 21, 2014 Minimum LIBOR Credit Agreement	Apr. 15, 2015 Minimum Base Rate Credit Agreement	Nov. 21, 2014 Minimum Base Rate Credit Agreement	Apr. 15, 2015 Maximum LIBOR Credit Agreement	Nov. 21, 2014 Maximum LIBOR Credit Agreement	Apr. 15, 2015 Maximum Base Rate Credit Agreement	Nov. 21, 2014 Maximum Base Rate Credit Agreement	Apr. 30, 2015 April 15, 2015 Credit Agreement	Apr. 30, 2015 April 16, 2015 through and including July 30, 2015 Credit Agreement	Apr. 30, 2015 July 31, 2015 through and including January 30, 2016 Credit Agreement	Apr. 30, 2015 January 31, 2016 through and including the maturity date Credit Agreement
Debt Instrument [Line Items]
Convertible Note				$ 8,500,000
Installment payments due	101,000
Borrowing under the revolving loan bears interest at a rate equal to LIBOR plus												5.25%	3.50%	4.25%	4.25%	3.25%	3.25%	6.25%	5.25%	5.25%	4.25%
Accrues interest rate			6.42%
Closing fee		116,000
Commitment fee percentage					0.40%
Revolving line of credit										5,000,000	10,000,000
Repayments of debt							7,400,000
Debt discount									315,000
Amortization of financing costs								355,000
Minimum liquidity																						5,000,000	6,500,000	7,000,000	7,500,000
Commitment fee in connection with the term loan						$ 3,000

Debt - Summary of Term Loan and Line of Credit (Details) (USD $) In Thousands, unless otherwise specified	Apr. 30, 2015	Jan. 31, 2015
Debt Instrument [Line Items]
Total	$ 11,041	$ 11,365
Less: Current portion	1,329	1,282
Non-current portion of debt	9,712	10,083
Senior Notes
Debt Instrument [Line Items]
Long-term debt	9,875	10,000
Capital Lease
Debt Instrument [Line Items]
Capital lease	$ 1,166	$ 1,365

Debt - Schedule of Future Principal Repayments of Long-Term Debt (Details) (USD $)
In Thousands, unless otherwise specified

Apr. 30, 2015

Capital Lease

2015

$ 641

^[1]

2016

511

^[1]

^[1]

^[1]

^[1]

1,245

^[1]

Maturities of Long-term Debt and Capital Lease Obligations [Abstract]

1,016

1,261

1,093

1,000

6,750

11,120

Senior Notes

375

750

1,000

1,000

6,750

$ 9,875

[1]	Future minimum lease payments include principal plus interest.

Debt - Note Payable Narrative (Details) (USD $)	3 Months Ended		1 Months Ended
Debt - Note Payable Narrative (Details) (USD $)	Apr. 30, 2015	Apr. 30, 2014	Nov. 30, 2013 Subordinated Debt	Nov. 30, 2013 Subordinated Debt Unsecured Subordinated Notes Due November, 2016
Debt Instrument [Line Items]
Debt term			3 years
Convertible Note			$ 900,000
Accrues interest rate			8.00%
Principal Payments			300,000
Repayments of debt	$ 125,000	$ 202,380		$ 600,000

Convertible Preferred Stock (Details) (USD $)	3 Months Ended
Convertible Preferred Stock (Details) (USD $)	Apr. 30, 2015
Class of Stock [Line Items]
Maximum period of conversion	10 days
Price per share at time of conversion	$ 3.00
Series A Preferred Stock
Class of Stock [Line Items]
Preferred stock, shares issued	2,949,995
Minimum share price	$ 8.00
Average daily trading volume minimum shares	100,000
Shares issued, price per share	$ 3.00

Income Taxes	3 Months Ended
Income Taxes	Apr. 30, 2015
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES Income tax expense consists of federal, state and local tax provisions. For the three months ended April 30, 2015 and 2014, we recorded federal tax benefit of $8,000 and zero, respectively. For the three months ended April 30, 2015 and 2014, we recorded state and local tax expense of $4,000 and $1,000, respectively.

Subsequent Events	3 Months Ended
Subsequent Events	Apr. 30, 2015
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	SUBSEQUENT EVENTS We have evaluated subsequent events for recognition or disclosure in the condensed consolidated financial statements filed on Form 10-Q with the SEC and no events have occurred that require disclosure, except for the following. In May 2015, we used the proceeds received from the Unibased escrow fund to make a $750,000 payment of principal towards the senior term loan with Wells Fargo.

Income Taxes (Details) (USD $)	3 Months Ended
Income Taxes (Details) (USD $)	Apr. 30, 2015	Apr. 30, 2014
Income Tax Disclosure [Abstract]
Federal tax provisions	$ 8,000	$ 0
State and local tax provisions	$ 4,000	$ 1,000

Subsequent Events (Details) (Senior Term Loan, Subsequent Event, USD $) In Thousands, unless otherwise specified	1 Months Ended
	May 31, 2015
Senior Term Loan \| Subsequent Event
Subsequent Event [Line Items]
Repayments of debt	$ 750